Ohio Attorney General Dave Yost announced that he along with 21 other attorneys general have secured final approval of a combined $17.3 billion settlement to hold two drug makers and two pharmacies accountable for their roles in the opioid-addiction crisis and help fund opioid recovery efforts.
Under the settlement, Ohio expects to receive a total of $679.6 million from drug makers Teva and Allergan and pharmacies CVS and Walgreens over the next 15 years.
Read the full story
The state of Georgia has signed on to a $3.1 billion national agreement with Walmart amid allegations that the retailer didn’t properly monitor opioids dispensing at its pharmacies; Georgia is expected to get $28 million in the deal, according to an announcement from Attorney General Chris Carr.
“The opioid epidemic has destroyed lives, families, and communities all across our state and nation,” Carr said in the release.
Read the full story
Virginia is expected to receive $60 million as part of a tentative $3.1 billion settlement agreement with Walmart after allegations of insufficient oversight of opioid dispensing at the chain’s pharmacies.
“Companies who facilitated the dispensing of opioids contributed to the opioid epidemic that has devastated millions of lives. This significant settlement will help us fight back against the epidemic and provide abatement and rehabilitation resources to suffering Virginians,” Attorney General Jason Miyares said in a press release.
Read the full story
Ohio Attorney General Dave Yost (R) announced on Tuesday that he and 15 other state attorneys general have negotiated a preliminary deal with the multinational retailer Walmart, from which Ohio would get $114 million for opioid recovery programs.
The $3.1 billion national agreement comes after Yost and other prosecutors sought accountability for what they characterize as the superstore’s failure to safely and securely dispense high-strength prescription pain relievers through its more than 5,100 pharmacies across America. Other state prosecutor’s offices who worked alongside him include California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Louisiana, Massachusetts, North Carolina, Nebraska, Pennsylvania, New York, Tennessee and Texas.
The agreement comes after Yost and other prosecutors sought accountability for what they characterize as the superstore’s failure to safely and securely dispense high-strength prescription pain relievers through its more than 5,100 pharmacies across America. Other state prosecutor’s offices who worked alongside him include California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Louisiana, Massachusetts, North Carolina, Nebraska, Pennsylvania, New York, Tennessee and Texas.
Virginia has received $67.4 million, the first payment in a Johnson and Johnson settlement requiring its subsidiary Janssen Pharmaceuticals to stop selling opioids in the U.S.; the Commonwealth will receive about $99.3 million total from the company over nine years.
“I’m thrilled that the money from these record-breaking settlements is on its way. My consumer protection section worked tirelessly to ensure that Virginians received the most funding possible and received it as quickly as possible. This helps the Commonwealth and individual localities fight back against the opioid epidemic and reduce, prevent, and treat addiction,” Attorney General Jason Miyares said in a press release.
Read the full story
Virginia localities have begun receiving payments from an opioid-related settlement with three distributors, which are separate from the state funding and total more than $4 million in the first installment.
McKesson, AmerisourceBergen and Cardinal Health agreed to pay the commonwealth and its localities about $530 million for allegedly being involved in higher overdose rates. Virginia will receive about $15 million and the Opioid Abatement Authority will receive more than $9.9 million in the first installment, in addition to the $4 million heading to localities.
Read the full story
Most Virginia localities were expected Friday to start receiving their share of the first payment in an opioid settlement, about $4.1 million split across the 133 localities. Additionally, Virginia’s Opioid Abatement Authority (OAA) will receive about $9.9 million, Attorney General Jason Miyares announced.
“I’m thrilled to announce that after a long period of waiting, the payments to Virginia’s Opioid Abatement Authority and to Virginia’s localities under this landmark settlement are on the way. Now, Virginia communities will be able to take actionable steps to fight back against the opioid epidemic, knowing that more help is on the way,” Miyares said in a press release.
Read the full story
Arizona Attorney General Mark Brnovich (R) recently announced two historic multistate settlements, totaling $26 billion, with four pharmaceutical companies over their roles in the opioid crisis.
“We are working to get these opioid abatement funds to local communities as quickly as possible,” Brnovich said in a press release. “They will help facilitate more effective treatment, education, and prevention as our state continues to tackle this heartbreaking crisis.”
Read the full story
Virginia expects about $530 million in a settlement over the opioid crisis with Johnson & Johnson along with pharmaceutical distributors Cardinal Health, McKesson, and AmerisourceBergen, according to a press release from the Office of the Attorney General. The companies announced Friday that there is enough participation by states, territories, and localities who were suing the drug companies to move forward with a national settlement, first announced in July 2021.
In his release, Attorney General Jason Miyares said, “The opioid crisis has devastated many Virginia communities, families, and lives. The Office of the Attorney General is dedicated to this fight and is proud to have played a role in this historic settlement, which every city and county in Virginia joined. Because of this, the Commonwealth expects to receive approximately $530 million dollars to fight back against the opioid epidemic and support efforts to reduce, prevent and treat opioid addiction.”
Read the full story
Fifty Pennsylvania counties have joined a historic global opioid settlement that is expected to bring $1 billion to the state to fight the opioid crisis.
The $26 billion settlement involves the nation’s three major pharmaceutical distributors – Cardinal, McKesson and AmerisourceBergen – as well as Johnson & Johnson. The agreement requires industry changes to help prevent a similar crisis in the future, in addition to the funds, Pennsylvania Attorney General Josh Shapiro said.
“Pennsylvania lost 5,172 lives to overdoses in the last year alone, which is 14 Pennsylvanians a day. This settlement is going to provide resources to jumpstart programs that will change lives and impact families across our commonwealth who are struggling to find treatment and help for those struggling with substance abuse,” Shapiro said. “These funds will be earmarked to offer and expand life-saving treatment options, prioritizing the areas that have been most affected by this crisis.”
Read the full story
Michigan could receive up to nearly $800 million from a proposed multibillion-dollar national opioid settlement with Johnson & Johnson and the three largest pharmaceutical distributors in the country: Cardinal Health, McKesson, and AmerisourceBergen.
Michigan Attorney General Dana Nessel officially signed the agreement announced last month for the companies role in the opioid epidemic.
Read the full story
Governor Ron DeSantis praised a multi-state agreement between three of the largest pharmaceutical companies in the nation, AmerisourceBergen, Cardinal Health, and McKesson, worth $21 billion.
DeSantis also praised a separate agreement by Johnson and Johnson who will pay $5 billion over the next nine years. The agreements will aim to settle litigation regarding the opioid crisis in not only Florida, but the nation as a whole.
Read the full story